Exane Derivatives’s Livent Corporation LTHM Stock Holding History

Exane Derivatives’s Portfolio LTHM Stock Details LTHM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.22K	Hold	98	–	–	﹤0.01%	429
2022 Q1	$2.56K	Hold	98	–	–	﹤0.01%	737
2021 Q4	$2.39K	Hold	98	–	–	﹤0.01%	653
2021 Q3	$2.27K	Hold	98	–	–	﹤0.01%	792
2021 Q2	$1.95K	Hold	98	–	–	﹤0.01%	820
2021 Q1	$1.7K	Hold	98	–	–	﹤0.01%	694
2020 Q4	$1.85K	Sell	98 -4,542	-98%	-$63.4K	﹤0.01%	633
2020 Q3	$41.6K	Buy	4,640 +4,408	+1,900%	+$33.2K	0.01%	384
2020 Q2	$1.43K	Sell	232 -4,398	-95%	-$27.7K	﹤0.01%	532
2020 Q1	$24.3K	Buy	+4,630	New	+$39K	0.01%	401
2019 Q3	–	Sell	-2,590	Closed	-$17.9K	–	707
2019 Q2	$17.9K	Hold	2,590	–	–	﹤0.01%	429
2019 Q1	$31.8K	Buy	+2,590	New	+$33.8K	0.01%	359

Other funds holding LTHM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Joho Capital New York $460M AUM 11.37% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Exane Derivatives's LTHM Position: Q2 2022 in Review

Exane Derivatives held its Livent Corporation (LTHM) position steady in Q2 2022 at 98 shares worth $2.22K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

Exane Derivatives first reported a position in LTHM in Q1 2019 and has held it in 12 quarters since. The position peaked at $41.6K in Q3 2020. 397 funds tracked by Wall St. Rank hold LTHM as of Q2 2022.

Exane Derivatives held 98 shares of Livent Corporation worth $2.22K as of Q2 2022.
Exane Derivatives left its Livent Corporation share count unchanged in Q2 2022.
Livent Corporation made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #429 holding.
Exane Derivatives first reported a position in Livent Corporation in Q1 2019 and has held it in 12 quarters since.
Exane Derivatives's Livent Corporation position peaked at $41.6K in Q3 2020.
397 funds tracked by Wall St. Rank held Livent Corporation as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.